الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 84 |  |  |
| | | from | 84 | | |
Abstract
In underdeveloped nations, PPH is a major contributor to maternal mortality since most PPH fatalities occur within the first 24 hours after giving birth. Proper use of prophylactic uterotonics during the third stage of labour may avert many of these problems.
So, this study set out to evaluate both rectal misoprostol and intravenous carbetocin for its ability to stop bleeding after childbirth.
During elective lower segment caesarean sections (L.S.C.S.), the major goal of our study is to examine the effectiveness of rectal misoprostol and intravenous carbetocin in preventing postpartum haemorrhage in low-risk people.
One hundred women participated in this randomized controlled trial; all of them gave birth through caesarean section under spinal anesthesia; patients in group A got one ampoule of carbetocin mixed with 10 mL of distilled water and administered intravenously (IV) immediately after giving birth. group B patients had lower segment caesarean section and were given two tablets of misoprostol retally after urinary catheter insertion prior to sterilization. Post-operative hemoglobin and hematocrit levels, as well as uterine atony, blood loss, blood transfusions, length of hospital stay, and transfusions were evaluated for each patient.
We found no statistically significant changes in age, parity, body mass index, or gestational age between patients who received IV carbetocin and patients who received rectal misoprostol when we compared the obstetric data of the examined groups.